Clinical Trials in Illinois

Showing 5241-5260 of 19,692 trials

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

NCT05972993

The purpose of this study is to evaluate the safety, reactogenicity and immune responses of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA-CR-04 vaccine construct when administered in healthy adults previously vaccinated with SARS-CoV-2 mRNA vaccines.

COVID-19

GlaxoSmithKline114 participantsStarted Aug 2023

San Diego, California, United States • Melbourne, Florida, United States • Peoria, Illinois, United States +1 more locations

COMPLETEDPhase 344 miles

Randomized Therapy In Status Epilepticus

NCT04391569

This study evaluated the effectiveness and safety of an investigational product (IP), intravenous (IV) ganaxolone, to treat participants with status epilepticus (SE).

Status Epilepticus

Marinus Pharmaceuticals100 participantsStarted Dec 2020

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +71 more locations

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

Randomized Therapy In Status Epilepticus

Find Trials by Condition in Illinois

Trial of Magrolimab (Hu5F9-G4) in Combination With Rituximab or Rituximab + Chemotherapy in Participants With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma

SPIROMICS Study of Early COPD Progression (SOURCE)

Modifiers of Disease Severity in Cerebral Cavernous Malformations

A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain

Combined Modality Therapy for Patients With With HIV and Stage I, Stage II, or Stage III Anal Cancer

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic Cancer

Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation

Multicenter Phenotype-Genotype Analysis of Vascular Stains to Optimize Treatment Utilizing Optical Coherence Tomography

Spatz3 Adjustable Balloon System® (Spatz3) Post Approval Study

Evaluating SUI-100™, A Non-Invasive Device for the Treatment of Stress Urinary Incontinence

RTA 402 in Patients With Advanced Solid Tumors or Lymphoid Malignancies

Safety and Tolerability of M254 in Healthy Volunteers and Immune Thrombocytopenic Purpura (ITP) Patients

Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors

Validation of ClarityDX Prostate as a Reflex Test to Refine the Prediction of Clinically-significant Prostate Cancer

An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism

Flexiva Pulse Registry

Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Chemotherapy-Induced Alopecia